Patents by Inventor Byron L Blagburn

Byron L Blagburn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230092636
    Abstract: Described herein are Dirofilarial exhalant signatures and methods of detecting a Dirofilaria signature in a non-blood biological sample, such as exhalant, that can be used to detect Dirofilarial infection in a subject, such as a canine.
    Type: Application
    Filed: November 17, 2022
    Publication date: March 23, 2023
    Inventors: Sarah M. Zohdy, Lindsay Starkey, Byron L. Blagburn
  • Patent number: 11549868
    Abstract: Described herein are Dirofilarial exhalant signatures and methods of detecting a Dirofilaria signature in a non-blood biological sample, such as exhalant, that can be used to detect Dirofilarial infection in a subject, such as a canine.
    Type: Grant
    Filed: September 29, 2021
    Date of Patent: January 10, 2023
    Assignee: AUBURN UNIVERSITY
    Inventors: Sarah M. Zohdy, Lindsay Starkey, Byron L. Blagburn
  • Publication number: 20220205878
    Abstract: Described herein are Dirofilarial exhalant signatures and methods of detecting a Dirofilaria signature in a non-blood biological sample, such as exhalant, that can be used to detect Dirofilarial infection in a subject, such as a canine.
    Type: Application
    Filed: September 29, 2021
    Publication date: June 30, 2022
    Inventors: Sarah M. Zohdy, Lindsay Starkey, Byron L. Blagburn
  • Patent number: 6994861
    Abstract: The present invention provides attenuated live cultures of the pathogenic protozoan parasite, Neospora, and live vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.
    Type: Grant
    Filed: September 24, 2003
    Date of Patent: February 7, 2006
    Assignee: Pfizer Inc
    Inventors: David A Brake, Byron L Blagburn, David S Lindsay
  • Publication number: 20040062772
    Abstract: The present invention provides attenuated live cultures of the pathogenic protozoan parasite, Neospora, and live vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.
    Type: Application
    Filed: September 24, 2003
    Publication date: April 1, 2004
    Applicant: PFIZER INC
    Inventors: David A. Brake, Byron L. Blagburn, David S. Lindsay
  • Patent number: 6656479
    Abstract: The present invention provides attenuated live cultures of the pathogenic protozoan parasite, Neospora, and live vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.
    Type: Grant
    Filed: September 12, 2001
    Date of Patent: December 2, 2003
    Assignee: Pfizer Inc.
    Inventors: David A Brake, Byron L Blagburn, David S Lindsay
  • Publication number: 20020044952
    Abstract: The present invention provides attenuated live cultures of the pathogenic protozoan parasite, Neospora, and live vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals.
    Type: Application
    Filed: September 12, 2001
    Publication date: April 18, 2002
    Inventors: David A. Brake, Byron L. Blagburn, David S. Lindsay
  • Patent number: 5668167
    Abstract: The present invention provides methods for treating Cryptococcus neoformans, Cryptosporidium parvum, and Candida albicans in a subject in need of such treatment. The methods comprises administering to the subject a compound of Formula I: ##STR1## wherein: X is located in the para or meta positions and is loweralkyl, loweralkoxy, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, alkylaryl, halogen, or ##STR2## wherein: each R.sub.2 is independently selected from the group consisting of H, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl or two R.sub.2 groups together represent C.sub.2 -C.sub.10 alkylene, or two R.sub.2 groups together represent ##STR3## wherein m is from 1-3 and R.sub.4 is H, ##STR4## or --CONHR.sub.5 NR.sub.6 R.sub.7, whereinR.sub.5 is loweralkyl, R.sub.6 and R.sub.7 are each independently selected from the group consisting of H and lower alkyl; each R.sub.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 16, 1997
    Assignees: Duke University, Auburn University, Georgia State University, The University of North Carolina at Chapel Hill
    Inventors: Richard R. Tidwell, James E. Hall, David W. Boykin, Christine C. Dykstra, John Perfect, Byron L. Blagburn
  • Patent number: 5622955
    Abstract: The present invention provides methods for treating Cryptosporidium parvum in a subject in need of such treatment.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: April 22, 1997
    Assignees: The University of North Carolina at Chapel Hill, Georgia State University Research Foundation, Inc., Auburn University
    Inventors: David W. Boykin, Christine C. Dykstra, Richard R. Tidwell, James E. Hall, W. David Wilson, Arvind Kumar, Byron L. Blagburn
  • Patent number: 5602172
    Abstract: The present invention provides methods for treating Pneumocystis carinii pneumonia, Giardia lamblia, and Cryptosporidium parvum in a subject in need of such treatment. The methods comprise adminstering to the subject a compound of Formula (I): ##STR1## wherein: R.sub.1 and R.sub.2 are each independently selected from the group consisting of H, loweralkyl, aryl, alkylaryl, aminoalkyl, aminoaryl, halogen, oxyalkyl, oxyaryl, or oxyarylalkyl;R.sub.3 and R.sub.4 are each independently selected from the group consisting of H, loweralkyl, oxyalkyl, alkylaryl, aryl, oxyaryl, aminoalkyl, aminoaryl, or halogen; andX and Y are located in the para or meta positions and are selected from the group consisting of H, loweralkyl, oxyalkyl, and ##STR2## wherein: each R.sub.5 is independently selected from the group consisting of H, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl or two R.sub.5 groups together represent C.sub.2 -C.sub.10 alkyl, hydroxyalkyl, or alkylene; andR.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: February 11, 1997
    Assignees: The University of North Carolina at Chapel Hill, Auburn University, Georgia State University Research Foundation, Inc.
    Inventors: David W. Boykin, Christine C. Dykstra, Richard R. Tidwell, James E. Hall, W. David Wilson, Arvind Kumar, Byron L. Blagburn